Safety and efficacy of once‐weekly semaglutide vs additional oral antidiabetic drugs in Japanese people with inadequately controlled type 2 diabetes: A randomized trial

AIM: To evaluate the safety and efficacy of once‐weekly subcutaneous semaglutide as monotherapy or combined with an oral antidiabetic drug (OAD) vs an additional OAD added to background therapy in Japanese people with type 2 diabetes (T2D) inadequately controlled on diet/exercise or OAD monotherapy....

Descripción completa

Detalles Bibliográficos
Autores principales: Kaku, Kohei, Yamada, Yuichiro, Watada, Hirotaka, Abiko, Atsuko, Nishida, Tomoyuki, Zacho, Jeppe, Kiyosue, Arihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5969242/
https://www.ncbi.nlm.nih.gov/pubmed/29322610
http://dx.doi.org/10.1111/dom.13218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5969242/
https://www.ncbi.nlm.nih.gov/pubmed/29322610
http://dx.doi.org/10.1111/dom.13218

Ejemplares similares